GM safflower oil byproduct approved as livestock feed

This article or excerpt is included in the GLP’s daily curated selection of ideologically diverse news, opinion and analysis of biotechnology innovation.

Arcadia Biosciences Inc. said Tuesday it has won approval from the U.S. Food and Drug Administration to sell a byproduct of its genetically modified safflower product as livestock feed.

The approval opens up a potentially large market of cattle and poultry producers for the Davis-based food technology company. It also “improves the overall production economics of GLA safflower oil,” CEO Eric Rey said in a news release.

For years, the company has sold its genetically modified safflower oil as a human nutritional supplement. The company now can market a byproduct of that oil, safflower seed meal, to animal-feed manufacturers.

Arcadia’s safflower seeds are high in omega-6 fatty acid, which some believe have anti-inflammation properties, as well as benefits for skin health, weight management and women’s hormonal balance.

The GLP aggregated and excerpted this blog/article to reflect the diversity of news, opinion and analysis. Read full, original post: Arcadia wins FDA approval to sell oil byproduct, opening up big new market

Share via
News on human & agricultural genetics and biotechnology delivered to your inbox.
Optional. Mail on special occasions.
Send this to a friend